Imbalances of chromosomes 4, 9, and 12 are recurrent in the thecoma-fibroma group of ovarian stromal tumors

Cancer Genetics and Cytogenetics

Volumn 178, Issue 2, 2007, Pages 135-140

  Streblow, Renae C ^a   Dafferner, Alicia J ^a   Nelson, Marilu ^b   Fletcher, Mavis ^a   West, William W ^a   Stevens, Rachel K ^a   Gatalica, Zoran ^c   Novak, Deborah ^c   Bridge, Julia A ^a,b  

^a NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANEUPLOIDY; ARTICLE; CHROMOSOME 12; CHROMOSOME 4; CHROMOSOME 9; CHROMOSOME DELETION; CHROMOSOME DELETION 4; CHROMOSOME GAIN; FEMALE; FIBROMA; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; KARYOTYPING; MEDICAL LITERATURE; NUMERICAL CHROMOSOME ABERRATION; OVARY TUMOR; PRIORITY JOURNAL; SCHOOL CHILD; THECOMA; TRISOMY 12; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ALLELIC IMBALANCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 4; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; FIBROMA; HUMANS; KARYOTYPING; MIDDLE AGED; OVARIAN NEOPLASMS; RECURRENCE; THECOMA;

EID: 35348860152     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.07.009     Document Type: Article

References (32)

1. Shashi V., Golden W.L., von Kap-Herr C., Andersen W.A., and Gaffey M.J. Interphase fluorescence in situ hybridization for trisomy 12 on archival ovarian sex cord-stromal tumors. Gynecol Oncol 55 (1994) 349-354
2. Zhang J., Young R.H., Arseneau I., and Scully R.E. Ovarian stromal tumors containing lutein or Leydig cells (luteinized thecomas and stromal Leydig cells)-a clinicopathological analysis of fifty cases. Int J Gynecol Pathol 1 (1982) 270-285
3. Gorlin R.J. Nevoid basal-cell carcinoma syndrome. Medicine (Baltimore) 66 (1987) 98-113
4. Tumours of the ovary and peritoneum. In: Tavassoli F.A., and Devilee P. (Eds). WHO Classification of Tumours: Pathology & Genetics of Tumours of the Breast and Female Genital Organs (2003), IARC Press, Lyon, France 149-151
5. Samuelson J., Katz S., Schwatz P.E., and Yang-Feng T.I. Chromosomal evolution through tumor progression in ovarian cancer. Am J Hum Genet Suppl. (1988) p. A33
6. Pejovic T., Heim S., Mandahl N., Elmfors B., Floderus U.M., Furgyik S., Helm G., Willen H., and Mitelman F. Trisomy 12 is a consistent chromosomal aberration in benign ovarian tumors. Genes Chromosome Cancer 2 (1990) 48-52
7. Leung W.Y., Schwartz P.E., Ng H.T., and Yang-Feng T.L. Trisomy 12 in benign fibroma and granulose cell tumor of the ovary. Gynecol Oncol 38 (1990) 28-31
8. Fletcher J.A., Gibas Z., Donovan K., Perez-Atayde A., Genest D., Morton C.C., and Lage J.M. 1991. Ovarian granulose-stromal cell tumors are characterized by trisomy 12. Am J Pathol 138 (1991) 515-520
9. Gancberg D., Scourneau M., Verdebout J.M., Larsimont D., and Verhest A. Detection of extra chromosomes 12 by fluorescent in situ hybridization (FISH) in ovarian stromal tumors. Study of 12 cases and review of the literature. Ann Pathol 21 (2001) 393-398
10. Mrózek K., Limon J., Debniak J., Emerich J., and Mrózek E. Trisomy 12 and 4 in a thecoma of the ovary. Gynecol Oncol 45 (1992) 66-68
11. Mrózek K., Nedoszytko B., Babinska M., Mrózek E., Hrabowska M., Emerich J., and Limon J. Trisomy of chromosome 12 in a case of thecoma of the ovary. Gynecol Oncol 36 (1990) 413-416
12. Walter T.A., Rieck J., Hossfeld D.K., and Walter L.T. An ovarian thecoma with a single numerical aberration: +12. Cancer Genet Cytogenet 71 (1993) 180-182
13. Izutsu T., Kudo T., Miura F., and Nishiya I. Numerical and structural chromosome abnormalities in an ovarian fibrothecoma. Cancer Genet Cytogenet 83 (1995) 84-86
14. Dal Cin P., Moerman P., De Wever I., and Van den Berghe H. Numerical chromosome aberrations in fibrothecoma. Tumori 78 (1992) 140-142
15. Dal Cin P., Qi H., Pauwels P., Backx C., and Van den Berghe H. Monosomy 22 in a fibrothecoma. Cancer Genet Cytogenet 99 (1997) 129-131
16. Liang S.B., Sonobe H., Taguchi T., Takeuchi T., Furihata M., Yuri K., and Ohtsuki Y. Tetrasomy 12 in ovarian tumors of thecoma-fibroma group: a fluorescence in situ hybridization analysis using paraffin sections. Pathol Int 51 (2001) 37-42
17. Smith L.M., Hu P., Meyer L.J., and Coffin C.M. Complex karyotpic abnormality in ovarian fibroma associated with Gorlin syndrome. Am J Med Genet 112 (2002) 61-64
18. Kiechle-Schwarz M., Pfleiderer A., Sreekantaiah C., Berger C.S., Medchill M.T., and Sandberg A.A. Cluster of trisomy 12 to tumors of the female genitourinary tract. Cancer Genet Cytogenet 54 (1991) 273-275
19. Schofield D.E., and Fletcher J.A. Trisomy 12 in pediatric granulose-stromal cell tumors. demonstration by a modified method of fluorescence in situ hybridization on paraffin-embedded material. Am J Pathol 141 (1992) 1265-1269
20. Taruscio D., Carcangiu M.L., and Ward D.C. Detection of trisomy 12 on ovarian sex cord stromal tumors by fluorescence in situ hybridization. Diagn Mol Pathol 2 (1993) 94-98
21. Persons D.L., Hartmann L.C., Herath J.F., Keeney G.L., and Jenkins R.B. Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors. Am J Clin Pathol 102 (1994) 775-779
22. Halperin D., Visscher D.W., Wallis T., and Lawrence W.D. Evaluation of chromosome 12 copy number in ovarian granulose cell tumors using interphase cytogenetics. Int J Gynecol Pathol 14 (1995) 319-323
23. Tsuji T., Kawauchi S., Utsunomiya T., Nagata Y., and Tsuneyoshi M. Fibrosarcoma versus cellular fibroma of the ovary: A comparative study of their proliferative activity and chromosome aberrations using MIB-1 immunostaining, DNA flow cytometry, and fluorescence in situ hybridization. Am J Surg Pathol 21 (1997) 52-59
24. Althof P.A., Ohmori K., Zhou M., Bailey J.M., Bridge R.S., Nelson M., Neff J.R., and Bridge J.A. Cytogenetic and molecular cytogenetic findings in 43 aneurysmal bone cysts: aberrations of 17p mapped to 17p13.2 by fluorescence in situ hybridization. Mod Pathol 17 (2004) 518-525
25. ISCN. An International System for Human Cytogenetic Nomenclature. In: Shaffer L., and Tommerup N. (Eds) (2005), S. Karger, Basel
26. Tsuji T., Catasus L., and Tsuji P.J. Is loss of heterozygosity at 9q22.3 (PTCH gene) and 19p13.3 (STK11 gene) involved in the pathogenesis of ovarian stromal tumors?. Hum Pathol 36 (2005) 792-796
27. Gorlin R.J., and Goltz R.W. Multiple nevoid basal cell epithelioma, jaw cysts and bifid rib syndrome. N Engl J Med 262 (1960) 908-912
28. Shanley S., Ratcliffe J., Hockey A., Haan E., Oley C., Ravine D., Martin N., Wicking C., and Chenevix-Trench G. Nevoid basal cell carcinoma syndrome: review of 118 affected individuals. Am J Med Genet 50 (1994) 282-290
29. Kimonis V.E., Goldstein A.M., Pastakia B., Yang M.L., Kase R., DiGiovanna J.J., Bale A.E., and Bale S.J. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 69 (1997) 299-308
30. Farndon P.A., Del Mastro R.G., Evans D.G.R., and Kilpatrick M.W. Location of gene for Gorlin syndrome. Lancet 339 (1992) 581-582
31. Chen Y., and Struhl G. Dual roles for Patched in sequestering and transducing Hedgehog. Cell 87 (1996) 553-563
32. Byrom J., Mudaliar V., Redman C.W., Jones P., Strange R.C., and Hoban P.R. Loss of heterozygosity at chromosome 9q22∼q31 is a frequent and early event in ovarian tumors. Int J Oncol 24 (2004) 1271